Patient characteristics
| Baseline characteristics | No ICH | ICH (except sICH) | sICH | P value* |
| Subjects, n (%) | 56 (64) | 20 (22) | 12 (14) | |
| Baseline variables | ||||
| Age in years, median (IQR) | 79 (65–86) | 76 (67–83) | 78 (77–83) | 0.90 |
| Female sex, n (%) | 26 (47) | 13 (65) | 7 (58) | 0.52 |
| Arterial hypertension, n (%) | 26 (46) | 10 (48) | 5 (40) | 0.36 |
| Cardioembolic aetiology, n (%) | 35 (62) | 9 (45) | 5 (40) | 0.14 |
| Prior anticoagulation or antiplatelet therapy, n (%) | 31 (55) | 12 (60) | 2 (17) | 0.36 |
| Admission NIHSS, median (IQR) | 16 (9–19) | 17 (13–21) | 17.5 (14–20) | 0.36 |
| ASPECTS, median (IQR) | 8 (7–9) | 6 (5–7) | 5 (5–7) | <0.001 |
| NWU, median (IQR) | 9.1 (3.0–14.1) | 10.3 (8.3–22.6) | 18.8 (16.2–27.9) | 0.007 |
| Treatment and endpoints | ||||
| IVT administration, n (%) | 29 (52) | 16 (80) | 9 (75) | 0.09 |
| mTICI 2b/3, n (%) | 46 (82) | 15 (77) | 9 (75) | 0.59 |
| Number of passes, median (IQR) | 2 (1–2) | 1 (1–3) | 1 (1–1) | 0.62 |
| NIHSS at 24 hours, median (IQR) | 15 (8–20) | 18 (11–23) | 24 (19–42) | 0.15 |
| mRS 0–2, n (%) | 20 (36) | 3 (15) | 1 (8.3) | 0.008 |
| mRS, median (IQR) | 4 (2–5.5) | 5 (3–6) | 5.5 (3.5–6) | 0.03 |
*Group comparison of patients with ICH versus without ICH.
ASPECTS, Alberta Stroke Program Early CT Score ; FUCT, follow-up computed tomography; ICH, intracerebral haemorrhage; IVT, intravenous thrombolysis with alteplase; mRS, modified Rankin Scale; mTICI, modified Thrombolysis In Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale; NWU, net water uptake; Pr, Probability; sICH, symptomatic ICH.